Quorum Innovations HHS STOMP initiative in Washington

Quorum Innovations has been invited to participate in the HHS STOMP initiative in Washington, D.C., recognizing the company’s growing role as a subject matter expert (SME) on microplastics and human health. This invitation places Quorum alongside federal leadership and key stakeholders working to better understand and address the impact of microplastic exposure. As a physician-scientist–founded organization with DARPA-validated barrier technologies and early human evidence demonstrating microplastic binding, Quorum is positioned to contribute both scientific insight and practical solutions. Their involvement reflects a broader shift toward proactive, prevention-focused strategies in public health. At the forefront of this national effort, Quorum will help shape the dialogue and direction of microplastics mitigation in the United States.   Quorum will also provide regular updates on the evolving direction and developments from the HHS STOMP program—stay tuned.